A gene change loosens DNA in DIPG, a childhood brain tumor
Original title: Disruption of lamina-associated genome organization activates neuronal gene programs in H3.3K27M DIPG
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This was done in cells in a lab, not in people.
The short version
Lab work found a new way that a gene change in DIPG switches on the wrong genes.
What was studied. Researchers looked at DIPG tumor samples and tumor cells grown from patients. They also put the same gene change, called H3K27M, into young nerve cells made from human stem cells.
What they found. In the DIPG cells, DNA pulled away from the edge of the cell's nucleus. Genes in those loosened spots turned on, including nerve genes and cancer genes. This loosening matched gene activity more closely than the known loss of a chemical tag on DNA. When the gene change was added to young nerve cells, the same loosening happened.
What this means, and what it doesn't
What it could mean: This helps explain one step in how DIPG cells go wrong. It gives researchers a new place to aim future work.
What it doesn't mean: This is early lab work in cells, not a test in children. It does not describe a new drug or treatment. It is not a cure, and it does not change care today. Work like this takes many years before it could reach patients, and most of it never does.
Source: bioRxiv (preprint), September 22, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.